Roche Holding Ltd. Genussscheine (VTX:ROG) received a CHF 320 target price from stock analysts at Goldman Sachs Group in a report issued on Friday, Borsen Zeitung reports. The firm presently has a “buy” rating on the healthcare company’s stock.
Several other equities research analysts have also recently commented on the company. Barclays upped their price target on Intuit from $225.00 to $237.00 and gave the stock an “equal weight” rating in a research note on Friday, May 24th. Oddo Bhf set a CHF 263 price target on Roche Holding Ltd. Genussscheine and gave the stock a “sell” rating in a research note on Tuesday, May 7th. UBS Group set a $160.00 price target on IBM and gave the stock a “buy” rating in a research note on Wednesday, April 17th. Credit Suisse Group set a €50.00 ($58.14) price target on Unilever and gave the stock a “neutral” rating in a research note on Thursday, April 18th. Finally, JPMorgan Chase & Co. restated a “sell” rating and set a $18.00 price target on shares of ABB in a research note on Monday, July 15th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of CHF 280.19.
Roche Holding Ltd. Genussscheine has a fifty-two week low of CHF 214.30 and a fifty-two week high of CHF 273.
About Roche Holding Ltd. Genussscheine
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense.
Read More: Do Tariffs Work?
Receive News & Ratings for Roche Holding Ltd. Genussscheine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. Genussscheine and related companies with MarketBeat.com's FREE daily email newsletter.